Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 25:11:550100.
doi: 10.3389/fonc.2021.550100. eCollection 2021.

Comparison of the Gross Target Volumes Based on Diagnostic PET/CT for Primary Esophageal Cancer

Affiliations

Comparison of the Gross Target Volumes Based on Diagnostic PET/CT for Primary Esophageal Cancer

Jingzhen Shi et al. Front Oncol. .

Abstract

Background: Clinically, many esophageal cancer patients who planned for radiation therapy have already undergone diagnostic Positron-emission tomography/computed tomography (PET/CT) imaging, but it remains unclear whether these imaging results can be used to delineate the gross target volume (GTV) of the primary tumor for thoracic esophageal cancer (EC).

Methods: Seventy-two patients diagnosed with thoracic EC had undergone prior PET/CT for diagnosis and three-dimensional CT (3DCT) for simulation. The GTV3D was contoured on the 3DCT image without referencing the PET/CT image. The GTVPET-ref was contoured on the 3DCT image referencing the PET/CT image. The GTVPET-reg was contoured on the deformed registration image derived from 3DCT and PET/CT. Differences in the position, volume, length, conformity index (CI), and degree of inclusion (DI) among the target volumes were determined.

Results: The centroid distance in the three directions between two different GTVs showed no significant difference (P > 0.05). No significant difference was found among the groups in the tumor volume (P > 0.05). The median DI values of the GTVPET-reg and GTVPET-ref in the GTV3D were 0.82 and 0.86, respectively (P = 0.006). The median CI values of the GTV3D in the GTVPET-reg and GTVPET-ref were 0.68 and 0.72, respectively (P = 0.006).

Conclusions: PET/CT can be used to optimize the definition of the target volume in EC. However, no significant difference was found between the GTVs delineated based on visual referencing or deformable registration whether using the volume or position. So, in the absence of planning PET-CT images, it is also feasible to delineate the GTV of primary thoracic EC with reference to the diagnostic PET-CT image.

Keywords: 18F-FDG PET/CT; deformable image registration; gross target volume; thoracic esophageal cancer; three-dimensional computed tomography.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A, B) Representative images in transversal, sagittal, and coronal sections show an ideal match between the before images and after images using DIR. The gray images represent images before deformable registration, and the red images represent images after deformable registration.
Figure 2
Figure 2
Representative images contoured in the image sessions in the transversal (a1), sagittal (a2), and coronal sections (a3) show differences among the three target volume delineations. The yellow contour represents the GTV3D, the red contour represents the GTVPET-ref, and the green contour represents the GTVPET-reg. GTV, gross target volume; GTV3D, GTV contoured based on 3DCT without referencing 18F-FDG PET/CT; GTVPET-ref, GTV contoured on 3DCT referencing 18F-FDG PET/CT; GTVPET-reg, GTV contoured on the deformed image derived from 3DCT and 18F-FDG PET/CT using MIM deformable registration software.

Similar articles

Cited by

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries. CA Cancer J Clin (2018) 68:394–424. 10.3322/caac.21492 - DOI - PubMed
    1. Zou B, Tu Y, Liao D, Xu Y, Wang J, Huang M, et al. . Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial? Thoracic Cancer (2020) 11(3):631–9. 10.1111/1759-7714.13307 - DOI - PMC - PubMed
    1. Ikeguchi M, Kohno Y, Kihara K, Suzuki K, Saito H. Neoadjuvant chemotherapy for clinical stage ii and iii thoracic esophageal squamous cell carcinoma with curative esophagectomy. J Cancer Ther (2015) 06(15):1207–13. 10.4236/jct.2015.615131 - DOI
    1. Chen M, Liu X, Han C, Liu P, Wang C, Zhao Y, et al. . Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R03A). CBMC Cancer (2020) 20(1):36. 10.1186/s12885-019-6461-z - DOI - PMC - PubMed
    1. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Wilke H. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol (2005) 23(10):2310–7. 10.1200/JCO.2005.00.034 - DOI - PubMed

LinkOut - more resources